TirzepatideRanked
Find my match
Price index re-read 2026-10-15 NexLife prices 2026-11-06 Methodology v4.1 Programs priced 28 Corrections open log

Core & Trust

About Tirzepatide Ranked

Who publishes this and how it is funded

Researched By Dr. Parmis · Medical Researcher · Western University of Health Sciences

Medically Reviewed By Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)

Last medically reviewed: · This page is informational and does not constitute medical advice.

Direct answer

Tirzepatide Ranked is published by S.J Partners LLC. We research what GLP-1 care costs in the United States, what providers actually promise, and what the clinical evidence does and does not establish. We are not a clinic, a pharmacy or a manufacturer.

Answer last reviewed:

Tirzepatide Ranked is published by S.J Partners LLC. We research what GLP-1 care costs in the United States, what providers actually promise, and what the clinical evidence does and does not establish. We are not a clinic, a pharmacy or a manufacturer.

Our test for every page is simple: could a reader check our work? If a number appears without a dated source, it should not have been published.

What we have verified so far
Verified — 15 (26%)Provider-reported — 36 (63%)Pending capture — 6 (11%)Outdated — 0 (0%)Sample placeholder — 0 (0%)57records
Show this figure as a table
Data table
StatusRecordsShare
Verified1526%
Provider-reported3663%
Pending capture611%
Outdated00%
Sample placeholder00%
Published as a metric on purpose. A dataset that hid its own gaps would overstate how transparent this market is.
What this page commits us to
What this page commits us to
AreaCommitmentHow you can check it
Every figureCarries a source and a capture dateOpen the provenance stamp beside it
Every clinical claimTraced to a primary sourceFollow the citation, not our summary
Every scoreComputed from published inputsRead the raw inputs on the provider page
Every correctionDated and permanentRead the corrections log
Every medical reviewDated on the pageRead “Last medically reviewed” in the byline

A dash means no figure held. How we grade evidence.

Who we are

Tirzepatide Ranked is published by S.J Partners LLC. The publisher is accountable for everything on the site: the rankings, the prices, the trial summaries, the corrections and the policies.

Research is led by Dr. Parmis, a medical researcher (Western University of Health Sciences), who traces each clinical claim back to its trial publication, trial registry entry or regulatory record. Clinical content is medically reviewed by Dr. Jonathan Snipes, MD (NPI 1821250077) and Kim Callender, NP (FNP-BC, NPI 1144661760), who check claims against those primary sources before a page publishes. Prices are read on each seller's own page, and the date we read them sits beside the figure.

What we are not:

  • We are not a clinic. Nobody here prescribes or gives individual medical advice.
  • We are not a pharmacy. We do not compound, dispense, sell or ship medicine.
  • We are not a manufacturer.
  • We do not collect your health details, and no page or tool on the site asks for them.

How this is funded

Tirzepatide Ranked is affiliate-supported. When you enroll with a provider through a link on this site, we may earn a commission.

That gives us a reason to favour whichever program pays, so the rules that keep money away from editorial decisions are fixed and public:

  • Scores come from the published methodology, version 4.1: seven categories, 100 points, with the inputs shown on each provider page.
  • Every price carries the date we read it on the seller's own page. See how we verify a price.
  • Mistakes are logged with a date and left visible on the corrections log.
  • Any provider we name can contest a fact, figure or score through the right to respond.

Compensation never changes our methodology, rankings or the prices we report. The full terms are in the affiliate and commercial disclosure.

What we publish and what we refuse to publish

We publish dated prices, scored rankings, trial summaries that keep every figure tied to its trial, dose and estimand, and plain explanations of FDA actions. We also publish our own gaps: a record we have not yet captured is shown as pending, not filled in with a guess.

We refuse to publish:

  • Any description of compounded tirzepatide as FDA-approved, as generic, or as the same product as Zepbound or Mounjaro. It is made with the drug in those products. It is not the same product.
  • Promises of weight loss. A trial result is a group average, not a forecast for you.
  • Prices copied from other review sites. If we could not read a figure on the seller's own page, we do not report it as a price.
  • "Cheapest" or "best" with nothing attached. The plan type, dose and date have to travel with the claim.
  • Dosing advice for an individual reader.
  • Placement, scores or reviews in exchange for payment.

How to check our work

You should be able to trace any number on this site to its source in about a minute. Four places let you do it:

  • Source ledger: each evidence ID, the source it points to and the date it was read.
  • Price records and the wider datasets: the figures behind the price index, in CSV and JSON. The index was last re-read on October 15, 2026: 33 compounded tirzepatide programs, $69 to $299 a month all-in, median $149. Twenty-three were read on the sellers' pages that day; five are older records and carry their older dates.
  • Methodology: the v4.1 rubric and the rules that override any score.
  • Methodology and dataset changelog: what changed in the rubric or the data, and when.

If what you find does not match what we published, tell us through the contact page. If we are wrong, the fix goes on the corrections log with the old wording still visible.

NexLife, first on our v4.1 methodology, charges $129 a month for compounded tirzepatide month to month, or $115 a month on a 12-month plan, with one price at every dose and no membership fee (read on nexlife.us, November 6, 2026). Check its current plans (opens nexlife.us in a new tab).

Cite this pageCC BY 4.0

Tirzepatide Ranked. “About Tirzepatide Ranked.” S.J Partners LLC, 2026-07-26. https://tirzepatideranked.com/about/

Quote the capture date beside a figure, not the date you read this page. Why.

Report an error
Comparing 0 of 4